Immix Biopharma, Inc.
IMMX
$1.99
-$0.42-17.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.54M | -4.81M | -7.15M | -4.39M | -5.26M |
| Total Depreciation and Amortization | 59.20K | 41.30K | 25.90K | 24.30K | 23.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 868.40K | 705.70K | 733.80K | 624.90K | 871.20K |
| Change in Net Operating Assets | 1.93M | 2.59M | 2.35M | -1.51M | 537.10K |
| Cash from Operations | -1.69M | -1.48M | -4.04M | -5.26M | -3.83M |
| Capital Expenditure | -67.70K | -507.20K | -271.50K | -97.10K | -301.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -67.70K | -507.20K | -271.50K | -97.10K | -301.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 0.00 | 15.95M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 0.00 | 0.00 | 0.00 | 15.95M |
| Foreign Exchange rate Adjustments | -8.00K | -25.10K | 23.00K | 8.90K | -10.40K |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | -- | -- | -- |
| Net Change in Cash | -1.76M | -2.01M | -4.28M | -5.34M | 11.81M |